Mar 09, 2026
Media Highlights
Pharma’s AI Investment Signals New Drug Discovery Paradigm
View on: GEN
Media Center
Mar 02, 2026
Media Highlights
Generate Arrives on Nasdaq Ready To Finally Show the World AI-Powered Medicines
View on: BioSpace
Feb 27, 2026
Media Highlights
AI-driven drug developer nets $400M IPO, matching 2020 record
View on: BBJ
Feb 26, 2026
Media Highlights
Flagship-Backed Generate Biomedicines Raises $400 Million in IPO
View on: Bloomberg
Jan 09, 2026
Media Highlights
PharmaVoice’s Crystal Ball: What’s next for AI and drug R&D
View on: PharmaVoice
Jan 02, 2026
Media Highlights
Long-acting anti-TSLP antibody for severe asthma moves into phase 3
View on: Healio
Dec 09, 2025
Media Highlights
What will be the first AI-designed drug? These disease-fighting antibodies are top contenders
View on: Nature
Dec 01, 2025
Media Highlights
Generate to launch Phase 3 TSLP drug studies, as AI bio enters its clinical era
View on: Endpoints News
Dec 01, 2025
Media Highlights
Somerville biotech says its AI-created asthma drug will enter late-stage trials
View on: Biz Journals